KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Cash & Current Investments (2018 - 2024)

BioNTech SE's Cash & Current Investments history spans 7 years, with the latest figure at $7.5 billion for Q4 2024.

  • For Q4 2024, Cash & Current Investments fell 57.86% year-over-year to $7.5 billion; the TTM value through Dec 2023 reached $17.8 billion, up 24.09%, while the annual FY2024 figure was $7.6 billion, 57.55% down from the prior year.
  • Cash & Current Investments for Q4 2024 was $7.5 billion at BioNTech SE, down from $17.8 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $17.8 billion in Q4 2023 and bottomed at $1.6 billion in Q4 2020.
  • The 5-year median for Cash & Current Investments is $14.3 billion (2022), against an average of $11.6 billion.
  • The largest annual shift saw Cash & Current Investments skyrocketed 929.4% in 2021 before it plummeted 57.86% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $1.6 billion in 2020, then surged by 929.4% to $16.5 billion in 2021, then decreased by 13.23% to $14.3 billion in 2022, then grew by 24.09% to $17.8 billion in 2023, then tumbled by 57.86% to $7.5 billion in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Cash & Current Investments are $7.5 billion (Q4 2024), $17.8 billion (Q4 2023), and $14.3 billion (Q4 2022).